|
1
|
Cha MJ, Lee HY, Lee KS, Jeong JY, Han J,
Shim YM and Hwang HS: Micropapillary and solid subtypes of invasive
lung adenocarcinoma: Clinical predictors of histopathology and
outcome. J Thorac Cardiovasc Surg. 147:921–928.e2. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ujiie H, Kadota K, Chaft JE, Buitrago D,
Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, et al:
Solid predominant histologic subtype in resected stage I lung
adenocarcinoma is an independent predictor of early, extrathoracic,
multisite recurrence and of poor postrecurrence survival. J Clin
Oncol. 33:2877–2884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu S, Xi J, Jiang W, Lu S and Wang Q:
Solid Component and Tumor Size Correlate With Prognosis of Stage IB
Lung Adenocarcinoma. Ann Thorac Surg. 99:961–967. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang X, Liu Y, Lian F, Guo L, Wen P, Liu
XY and Lin DM: Lepidic and micropapillary growth pattern and
expression of Napsin A can stratify patients of stage I lung
adenocarcinoma into different prognostic subgroup. Int J Clin Exp
Pathol. 7:1459–1468. 2014.PubMed/NCBI
|
|
5
|
Zhang Y, Wang R, Cai D, Li Y, Pan Y, Hu H,
Wang L, Li H, Ye T, Luo X, et al: A comprehensive investigation of
molecular features and prognosis of lung adenocarcinoma with
micropapillary component. J Thorac Oncol. 9:1772–1778. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 1:10–29. 2012. View Article : Google Scholar
|
|
7
|
Lortettieulent J, Soerjomataram I, Ferlay
J, Rutherford M, Weiderpass E and Bray F: International trends in
lung cancer incidence by histological subtype: adenocarcinoma
stabilizing in men but still increasing in women. Lung Cancer.
84:13–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith CB, Kelley AS and Meier DE: Evidence
for new standard of care in non-small cell lung cancer patients.
Semin Thorac Cardiovasc Surg. 22:193–194. 2011. View Article : Google Scholar
|
|
9
|
Kishimoto K, Nishizuka M, Ueda T, Kajita
K, Ugawa S, Shimada S, Osada S and Imagawa M: Indispensable role of
factor for adipocyte differentiation 104 (fad104) in lung
maturation. Exp Cell Res. 317:2110–2123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tominaga K, Kondo C, Johmura Y, Nishizuka
M and Imagawa M: The novel gene fad104, containing a fibronectin
type III domain, has a significant role in adipogenesis. FEBS Lett.
577:49–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nishizuka M, Kishimoto K, Kato A, Ikawa M,
Okabe M, Sato R, Niida H, Nakanishi M, Osada S and Imagawa M:
Disruption of the novel gene fad104 causes rapid postnatal death
and attenuation of cell proliferation, adhesion, spreading and
migration. Exp Cell Res. 315:809–819. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kishimoto K, Kato AS, Nishizuka M and
Imagawa M: Fad104, a positive regulator of adipogenesis, negatively
regulates osteoblast differentiation. Biochem Biophys Res Commun.
397:187–191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin F, Ren XD, Pan Z, Macri L, Zong WX,
Tonnesen MG, Rafailovich M, Bar-Sagi D and Clark RA: Fibronectin
growth factor-binding domains are required for fibroblast survival.
J Invest Dermatol. 131:84–98. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Obara M, Sakuma T and Fujikawa K: The
third type III module of human fibronectin mediates cell adhesion
and migration. J Biochem. 147:327–335. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin CH, Lin YW, Chen YC, Liao CC, Jou YS,
Hsu MT and Chen CF: FNDC3B promotes cell migration and tumor
metastasis in hepatocellular carcinoma. Oncotarget. 7:49498–49508.
2016.PubMed/NCBI
|
|
16
|
Sung WJ, Kim H and Park KK: The biological
role of epithelial-mesenchymal transition in lung cancer (Review).
Oncol Rep. 36:1199–1206. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weber CE, Li NY, Wai PY and Kuo PC:
Epithelial-mesenchymal transition, TGF-Î2, and osteopontin in wound
healing and tissue remodeling after injury. J Burn Care Res.
33:311–318-. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
19
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428-.
2015. View
Article : Google Scholar
|
|
20
|
Cai C, Rajaram M, Zhou X, Liu Q, Marchica
J, Li J and Powers RS: Activation of multiple cancer pathways and
tumor maintenance function of the 3q amplified oncogene FNDC3B.
Cell Cycle. 11:1773–1781. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sabattini E, Bisgaard K, Ascani S, Poggi
S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G and
Pileri SA: The EnVision++ system: a new immunohistochemical method
for diagnostics and research. Critical comparison with the APAAP,
ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol.
51:506–511. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui Y, Liu J, Yin HB, Liu YF and Liu JH:
Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.
Jpn J Clin Oncol. 45:854–859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Gai L, Liu J, Cui Y, Zhang Y and
Feng J: Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as
a negative regulator of EMT and its clinical value. Int J Clin Exp
Pathol. 8:7165–7172. 2015.PubMed/NCBI
|
|
25
|
Brzozowska A, Sodolski T, Duma D,
Mazurkiewicz T and Mazurkiewicz M: Evaluation of prognostic
parameters of E-cadherin status in breast cancer treatment. Ann
Agric Environ Med. 19:541–546. 2012.PubMed/NCBI
|
|
26
|
Xu B, Jin DY, Lou WH and Wang DS:
Lipocalin-2 is associated with a good prognosis and reversing
epithelial-to-mesenchymal transition in pancreatic cancer. World J
Surg. 37:1892–1900. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu MM, Mao GX, Liu J, Li JC, Huang H, Liu
YF and Liu JH: Low expression of the FoxO4 gene may contribute to
the phenomenon of EMT in non-small cell lung cancer. Asian Pac J
Cancer Prev. 15:4013–4018-. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bian T, Jiang D, Liu J, Yuan X, Feng J, Li
Q, Zhang Q, Li X, Liu Y and Zhang J: miR-1236-3p suppresses the
migration and invasion by targeting KLF8 in lung adenocarcinoma
A549 cells. Biochem Biophys Res Commun. 492:461–467. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen CF, Hsu EC, Lin KT, Tu PH, Chang HW,
Lin CH, Chen YJ, Gu DL, Lin CH, Wu JY, et al: Overlapping
high-resolution copy number alterations in cancer genomes
identified putative cancer genes in hepatocellular carcinoma.
Hepatology. 52:1690–1701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fan X, Xu C, Deng W, Zhong G, Cai Q and
Lin T: Upregulated microRNA-143 in cancer stem cells
differentiation promotes prostate cancer cells metastasis by
modulating FNDC3B expression. BMC Cancer. 13:612013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shan ZZ, Yan XB, Yan LL, Tian Y, Meng QC,
Qiu WW, Zhang Z and Jin ZM: Overexpression of Tbx3 is correlated
with Epithelial-Mesenchymal Transition phenotype and predicts poor
prognosis of colorectal cancer. Am J Cancer Res. 5:344–353.
2015.PubMed/NCBI
|
|
33
|
Koren A, Motaln H and Cufer T: Lung cancer
stem cells: a biological and clinical perspective. Cell Oncol
(Dordr). 36:265–275. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial|[ndash]|mesenchymal transitions. Nat Rev Mol
Cell Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi Y, Wu H, Zhang M, Lei D, Meng F and
Fan X: Expression of the epithelial-mesenchymal transition-related
proteins and their clinical significance in lung adenocarcinoma.
Diagnostic Pathology. 8:89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goto M, Osada S, Imagawa M and Nishizuka
M: FAD104, a regulator of adipogenesis, is a novel suppressor of
TGF-β mediated EMT in cervical cancer cells. Sci Rep. 7:163652017.
View Article : Google Scholar : PubMed/NCBI
|
